Puro Pharmaceutical: Net profit in the first half of 2025 was 563 million Yuan, a year-on-year decrease of 9.89%.

Puluo Pharmaceutical announced that the operating income for the first half of 2025 was 5.44 billion yuan, a year-on-year decrease of 15.31%. Net profit was 563 million yuan, a year-on-year decrease of 9.89%. The company plans to distribute a cash dividend of 3.48 yuan per 10 shares to all shareholders.